Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric nanoparticle form of thyroid hormone agonist, partial agonist or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Nanoparticle forms of thyroid hormone or thyroid hormone analogs as well as uses thereof are also disclosed.

A product including ultrafine natural glass, methods of producing the ultrafine natural glass, and methods of use thereof are provided. The product may have, for example, a small top cut (d.sub.99) particle size of, for example, less than 12 microns. The product may also have high blue light brightness higher than, for example, 69, and/or low oil absorption, for example, less than 100 percent in volume. The product may be used in a variety of applications, such as, for example, anti-block filler in plastic films and/or reinforcement filler in polymers.

Provided are a porous silicon-based anode active material including crystalline silicon (Si) particles, and a plurality of pores on surfaces, or the surfaces and inside of the crystalline silicon particles, wherein at least one plane of crystal planes of at least a portion of the plurality of pores includes a (100) plane, and a method of preparing the porous silicon-based anode active material. Since a porous silicon-based anode active material of the present invention may allow volume expansion, which is occurred during charge and discharge of a lithium secondary battery, to be concentrated on pores instead of the outside of the anode active material, the porous silicon-based anode active material may improve life characteristics of the lithium secondary battery by efficiently controlling the volume expansion.

A carbon dioxide adsorbent includes a porous metal oxide represented by Chemical Formula 1, the porous metal oxide having a specific surface area of greater than or equal to about 30 m.sup.2/g, and an average pore size of greater than or equal to about 2 nm.

A flocculant, according to embodiments of the present disclosure, includes a core nanoparticle and at least one positively charged functional group on a surface of the core nanoparticle. The nanoparticle may comprise a silica, alumina, titania, iron oxide, iron nitride, iron carbide, or a carbon-based nanoparticle. The flocculant may be used, in a method of bitumen recovery, to neutralize and agglomerate bitumen droplets and/or mineral particles derived from oil sands ore. The bitumen droplets agglomerate about the core nanoparticle of the flocculant to form bitumen flocs, while the mineral particles agglomerate about the core nanoparticle of the flocculant to form mineral flocs. The buoyant bitumen flocs may then separate from the dense mineral flocs to enable high-yield recovery of bitumen from oil sands.

Methods of producing graphene nanoplatelets by exposing graphite to a medium to form a dispersion of graphite in the medium. In some embodiments, the exposing results in formation of graphene nanoplatelets from the graphite. In some embodiments, the medium includes the following components: (a) an acid; (b) a dehydrating agent; and (c) an oxidizing agent. In some embodiments, the methods of the present disclosure result in the formation of graphene nanoplatelets at a yield of more than 90%. In some embodiments, the methods of the present disclosure result in the formation of graphene nanoplatelets in bulk quantities that are more than about a 1 kg of graphene nanoplatelets. Additional embodiments of the present disclosure pertains to the formed graphene nanoplatelets. In some embodiments, the graphene nanoplatelets include a plurality of layers, such as from about 1 layer to about 100 layers.

Disclosed is AA′ graphite with a new stacking feature of graphene, and a fabrication method thereof. Graphene is stacked in the sequence of AA′ where alternate graphene layers exhibiting the AA′ stacking are translated by a half hexagon (1.23 Å). AA′ graphite has an interplanar spacing of about 3.44 Å larger than that of the conventional AB stacked graphite (3.35 Å) that has been known as the only crystal of pure graphite. This may allow the AA′ stacked graphite to have unique physical and chemical characteristics.

Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.

Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m.sup.2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.

The present invention refers to a mineral matter powder preparation by wet process without acrylic additive or other grinding aid additives and to Me use of said mineral matter after an optional hydrophobic treatment. Said mineral material Having superior dispersing properties.